• FDA Drug Approvals Up 42% in 2011, Regulatory Quality Highlighted

    The US Food and Drug Administration (FDA) approved 30 new molecular entities (NMEs) during 2011, marking a 7-year high for the agency, according to an analysis by Bloomberg . Notable success stories include Johnson & Johnson and GlaxoSmithkline, both of which tripled their approvals from the year prior.  The entire industry, however, may stand to benefit from the 42% increase in approvals as patent expiries begin in earnest this year. Twenty-one patented me...